Sign In

Login

Password

Forgot Password ? Sign Up

Piperacillina (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Piperacillina" in Italian language version.

refsWebsite
Global rank Italian rank
34nih.gov
4th place
9th place
2oadoi.org
799th place
22nd place
2doi.org
2nd place
7th place
1fda.gov
447th place
644th place

doi.org

dx.doi.org

fda.gov

nih.gov

ncbi.nlm.nih.gov

  • K. Ueo, Y. Fukuoka; T. Hayashi; T. Yasuda; H. Taki; M. Tai; Y. Watanabe; I. Saikawa; S. Mitsuhashi, In vitro and in vivo antibacterial activity of T-1220, a new semisynthetic penicillin., in Antimicrob Agents Chemother, vol. 12, n. 4, Ott 1977, pp. 455-60, PMID 921239.
  • TA. Kadima, JH. Weiner, Mechanism of suppression of piperacillin resistance in enterobacteria by tazobactam., in Antimicrob Agents Chemother, vol. 41, n. 10, Ott 1997, pp. 2177-83, PMID 9333044.
  • KP. Fu, HC. Neu, Piperacillin, a new penicillin active against many bacteria resistant to other penicillins, in Antimicrob Agents Chemother, vol. 13, n. 3, Mar 1978, pp. 358-67, PMID 122519.
  • L. Verbist, In vitro activity of piperacillin, a new semisynthetic penicillin with an unusually broad spectrum of activity, in Antimicrob Agents Chemother, vol. 13, n. 3, Mar 1978, pp. 349-57, PMID 122518.
  • GR. Monif, PR. Clark; JJ. Shuster; H. Baer, Susceptibility of the anaerobic bacteria, group D streptococci, Enterobacteriaceae, and Pseudomonas to semisynthetic penicillins: carbenicillin, piperacillin, and ticarcillin., in Antimicrob Agents Chemother, vol. 14, n. 5, Nov 1978, pp. 643-9, PMID 103491.
  • DJ. Winston, D. Wang; LS. Young; WJ. Martin; WL. Hewitt, In vitro studies of piperacilin, a new semisynthetic penicillin, in Antimicrob Agents Chemother, vol. 13, n. 6, Giu 1978, pp. 944-50, PMID 677861.
  • K. Iida, S. Hirata; S. Nakamuta; M. Koike, Inhibition of cell division of Escherichia coli by a new synthetic penicillin, piperacillin., in Antimicrob Agents Chemother, vol. 14, n. 2, Ago 1978, pp. 257-66, PMID 358919.
  • MA. Evans, P. Wilson; T. Leung; JD. Williams, Pharmacokinetics of piperacillin following intravenous administration., in J Antimicrob Chemother, vol. 4, n. 3, Mag 1978, pp. 255-61, PMID 670119.
  • MI. Thompson, ME. Russo; JM. Matsen; E. Atkin-Thor, Piperacillin pharmacokinetics in subjects with chronic renal failure., in Antimicrob Agents Chemother, vol. 19, n. 3, Mar 1981, pp. 450-3, PMID 6454382.
  • M. Dupon, G. Janvier; G. Vinçon; S. Winnock; F. Demotes-Mainard; O. Capeyron; J. Saric, Plasma levels of piperacillin and vancomycin used as prophylaxis in liver transplant patients., in Eur J Clin Pharmacol, vol. 45, n. 6, 1993, pp. 529-34, PMID 8157038.
  • JM. Decazes, A. Meulemans; A. Bure; MJ. Laisne; J. Modai, [Penetration of piperacillin into the cerebrospinal fluid of patients with purulent meningitis]., in Presse Med, vol. 13, n. 5, Feb 1984, pp. 261-4, PMID 6229775.
  • JP. Akbaraly, S. Guibert; JJ. Leng; J. Auzerie, [Transplacental transfer of 5 antibiotics by in vitro human placental perfusion]., in Pathol Biol (Paris), vol. 33, n. 5, Mag 1985, pp. 368-72, PMID 3897968.
  • MC. Thirumoorthi, BI. Asmar; JA. Buckley; RO. Bollinger; RE. Kauffman; AS. Dajani, Pharmacokinetics of intravenously administered piperacillin in preadolescent children., in J Pediatr, vol. 102, n. 6, Giu 1983, pp. 941-6, PMID 6222169.
  • DH. Wittmann, A clinical evaluation of piperacillin in intra-abdominal infections., in Clin Ther, 6 Suppl A, 1984, pp. 35-44, PMID 6380726.
  • HC. Polk, MP. Fink; M. Laverdiere; SE. Wilson; GE. Garber; PS. Barie; JC. Hebert; WG. Cheadle, Prospective randomized study of piperacillin/tazobactam therapy of surgically treated intra-abdominal infection. The Piperacillin/Tazobactam Intra-Abdominal Infection Study Group., in Am Surg, vol. 59, n. 9, Set 1993, pp. 598-605, PMID 8396374.
  • M. Seki, Y. Higashiyama; Y. Imamura; S. Nakamura; S. Kurihara; K. Izumikawa; H. Kakeya; Y. Yamamoto; K. Yanagihara; T. Tashiro; S. Kohno, A clinical comparative study of piperacillin and sulbactam/ampicillin in patients with community-acquired bacterial pneumonia., in Intern Med, vol. 48, n. 1, 2009, pp. 49-55, PMID 19122356.
  • SJ. Edwards, S. Wordsworth; MJ. Clarke, Treating pneumonia in critical care in the United Kingdom following failure of initial antibiotic: a cost-utility analysis comparing meropenem with piperacillin/tazobactam., in Eur J Health Econ, vol. 13, n. 2, Apr 2012, pp. 181-92, DOI:10.1007/s10198-011-0296-0, PMID 21243514.
  • SJ. Landis, R. Ramphal; BJ. Mansheim; KH. Rand; JW. Shands, Comparative efficacy of piperacillin and penicillin G in treatment of gonococcal urethritis., in Antimicrob Agents Chemother, vol. 20, n. 5, Nov 1981, pp. 693-5, PMID 6459764.
  • ML. Simpson, MY. Khan; Y. Siddiqui; RP. Gruninger; DI. Wigren, Comparison of piperacillin and penicillin in the treatment of uncomplicated gonorrhea., in Antimicrob Agents Chemother, vol. 21, n. 5, Mag 1982, pp. 727-9, PMID 6213195.
  • RG. Masterton, NA. Harrison, Single dose piperacillin in gonococcal urethritis., in Genitourin Med, vol. 64, n. 2, Apr 1988, pp. 134-5, PMID 3384432.
  • CD. Settle, MH. Wilcox; WN. Fawley; OJ. Corrado; PM. Hawkey, Prospective study of the risk of Clostridium difficile diarrhoea in elderly patients following treatment with cefotaxime or piperacillin-tazobactam., in Aliment Pharmacol Ther, vol. 12, n. 12, Dic 1998, pp. 1217-23, PMID 9882029.
  • O. Dörner, C. Piper; HP. Dienes; PA. Berg; H. von Egidy, [Acute interstitial nephritis following piperacillin]., in Klin Wochenschr, vol. 67, n. 13, Lug 1989, pp. 682-6, PMID 2755033.
  • J. Soto, JM. Bosch; MJ. Alsar Ortiz; MJ. Moreno; JD. Gonzalez; JM. Diaz, Piperacillin-induced acute interstitial nephritis., in Nephron, vol. 65, n. 1, 1993, pp. 154-5, PMID 8413777.
  • H. Tanaka, S. Waga; Y. Kakizaki; T. Tateyama; M. Koda; M. Yokoyama, Acute tubulointerstitial nephritis associated with piperacillin therapy in a boy with glomerulonephritis., in Acta Paediatr Jpn, vol. 39, n. 6, Dic 1997, pp. 698-700, PMID 9447761.
  • MW. Pill, CV. O'Neill; MM. Chapman; AK. Singh, Suspected acute interstitial nephritis induced by piperacillin-tazobactam., in Pharmacotherapy, vol. 17, n. 1, pp. 166-9, PMID 9017778.
  • MH. Scheetz, JM. McKoy; JP. Parada; B. Djulbegovic; DW. Raisch; PR. Yarnold; J. Zagory; S. Trifilio; R. Jakiche; F. Palella; A. Kahn, Systematic review of piperacillin-induced neutropenia., in Drug Saf, vol. 30, n. 4, 2007, pp. 295-306, PMID 17408306.
  • PG. Brock, M. Roach, Adverse reactions to piperacillin in cystic fibrosis., in Lancet, vol. 1, n. 8385, Mag 1984, pp. 1070-1, PMID 6143994.
  • B. Strandvik, Adverse reactions to piperacillin in patients with cystic fibrosis., in Lancet, vol. 1, n. 8390, Giu 1984, p. 1362, PMID 6145065.
  • RJ. Stead, HG. Kennedy; ME. Hodson; JC. Batten, Adverse reactions to piperacillin in cystic fibrosis., in Lancet, vol. 1, n. 8381, Apr 1984, pp. 857-8, PMID 6143174.
  • RJ. Stead, HG. Kennedy; ME. Hodson; JC. Batten, Adverse reactions to piperacillin in adults with cystic fibrosis., in Thorax, vol. 40, n. 3, Mar 1985, pp. 184-6, PMID 3983886.
  • RA. Pleasants, TR. Walker; WM. Samuelson, Allergic reactions to parenteral beta-lactam antibiotics in patients with cystic fibrosis., in Chest, vol. 106, n. 4, Ott 1994, pp. 1124-8, PMID 7924483.
  • JS. Parmar, S. Nasser, Antibiotic allergy in cystic fibrosis., in Thorax, vol. 60, n. 6, Giu 2005, pp. 517-20, DOI:10.1136/thx.2004.027953, PMID 15923254.
  • R. Lang, M. Lishner; M. Ravid, Adverse reactions to prolonged treatment with high doses of carbenicillin and ureidopenicillins., in Rev Infect Dis, vol. 13, n. 1, pp. 68-72, PMID 2017635.
  • R. Sannerstedt, P. Lundborg; BR. Danielsson; I. Kihlström; G. Alván; B. Prame; E. Ridley, Drugs during pregnancy: an issue of risk classification and information to prescribers., in Drug Saf, vol. 14, n. 2, Feb 1996, pp. 69-77, PMID 8852521.

oadoi.org